Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
In England, 3 in 4 people with chronic liver disease are only diagnosed during an emergency hospital admission — but a Nottinghamshire initiative is flipping that script. The Scarred Liver Project brings FibroScan technology to libraries, leisure centres, and a mobile van, targeting high-risk patients before symptoms strike. Now a commissioned NHS service, it's a model for proactive, community-based liver disease detection.
In England, three in four people with chronic liver disease are first diagnosed during an emergency hospital admission — a statistic that a Nottinghamshire-based initiative is working hard to change. The Scarred Liver Project uses FibroScan, a non-invasive ultrasound tool that measures liver stiffness, to screen high-risk individuals in community settings like GP practices, libraries, leisure centres, and even a roaming van. What started as a research study is now a fully commissioned NHS service — the first of its kind to allow GPs to directly refer patients for liver scanning based on risk factors like obesity, type 2 diabetes, and hazardous alcohol use.
The project has a particular focus on health equity, actively targeting the most deprived communities where liver disease burden is highest. By meeting patients where they are — rather than waiting for them to show up at a hospital — the initiative has demonstrated that early detection is both feasible and impactful.
By the Numbers
Why it matters: Chronic liver disease is a leading cause of premature death, yet it often progresses silently until it's too late. The Scarred Liver Project shows that community-based, proactive screening can shift the dial — catching disease early enough for lifestyle changes to reverse fibrosis, easing pressure on hospitals, and saving lives.
